Driving breakthrough discoveries for better healthcare outcomes.
Explore SPARC’s work in action, including panel discussions, articles, and more.
Precision medicine is transforming health care, but uneven representation in genetic research limits its reach and equity. This session explores how global collaboration, inclusive infrastructure, and philanthropic investment can ensure that precision medicine benefits all populations.
The Baszucki Brain Research Fund and the Milken Institute announced the annual recipients of the 2022 Metabolic Mind Awards, which reward clinicians for their work in advancing Ketogenic Metabolic Therapy for mental disorders. 
Type 1 diabetes has no cure, but early screening can improve outcomes. Supported by the Helmsley Charitable Trust, this SPARC report outlines a roadmap to implement widespread T1D autoantibody screening.
SPARC released an updated road map for implementing T1D autoantibody screening, highlighting progress, ongoing challenges, and opportunities for collaboration to expand screening in the general population.
SPARC and Tambourine Philanthropies partnered to analyze ALS funding and research. This guide pinpoints where focused philanthropy can accelerate progress.
Sarcoidosis is a complex, underfunded disease. In partnership with the Ann Theodore Foundation, SPARC launched the Breakthrough Sarcoidosis Initiative to accelerate research, foster collaboration, and drive progress.
Bipolar disorder is complex and poorly understood, but large-scale collaborative research backed by philanthropy could transform care and treatment.
Dave Baszucki, co-founder of the Baszucki Group, was featured on this panel along with Cara Altimus, managing director, SPARC, where leaders shared how they have shaped their philanthropic giving for science by leveraging insights from their success in business.
SPARC’s report outlines how philanthropy can accelerate progress in pediatric preventive care across conditions. It provides a framework for advancing science, policy, and investment in prevention to improve lifelong health outcomes.
A lack of shared definition has long hindered progress in misophonia research. To address this, SPARC convened experts to develop a consensus definition.
The Follicular Lymphoma Foundation has launched the CURE FL Awards, a new grant program managed by Milken Institute’s Center for Strategic Philanthropy.
Neurotechnology offers powerful new ways to treat brain disorders. SPARC’s Giving Smarter Guide, funded by the BrightFocus Foundation, highlights key opportunities for philanthropy to advance research, innovation, and collaboration in the field.